潜在的下一代目标,用于抗菌剂的发现和开发
Pooja Gupta1, Pushplata Yadav2, Manjul Lata2
1Molecular Microbiology and Immunology Division, CSIR-Central Drug Research Institute, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, Uttar Pradesh, India; Jawaharlal Nehru University, New Mehrauli Road, JNU Ring Road, New Delhi, 110067, India.
European journal of medicinal chemistry
|October 2, 2025
概括
抗生素耐药性是一个全球危机,威胁着后抗生素时代. 本次审查确定了28种新型抗菌点和分子,以加快新药的开发.
科学领域:
- 微生物学与传染病的研究
- 药物发现和开发 药物发现和开发
- 公共卫生 公共卫生
背景情况:
- 抗微生物药物耐药性 (AMR) 是一个严重的全球卫生危机,由不适当的抗微生物药物使用和演变驱动.
- 新抗生素的管道非常低,几乎没有新的作用机制,将医学推向后抗生素时代.
- 现有的候选药物通常会失败,因为它们是当前抗生素的衍生品或已经表现出耐药性的向途径.
研究的目的:
- 通过确定尚未探索的目标来解决对新型抗菌剂的迫切需求.
- 审查最近发现的具有抗菌活性的分子及其潜在目标.
- 为协调药物开发和降低下一代抗生素消耗率提供战略.
主要方法:
- 对过去五年的科学出版物进行了全面的文献审查.
- 识别和总结可行的,尚未探索的抗菌点.
- 对新型抗菌分子及其作用机制的分析.
主要成果:
- 确定了28个可行的尚未探索的目标,用于开发新型抗菌药物.
- 编制了最近文献中报告的新型抗菌分子及其潜在点的清单.
- 对抗菌药物开发中的关键挑战,缺口和战略方法的概述.
结论:
- 迫切需要新的抗微生物药物,具有新的机制,以应对抗微生物药物耐药性日益增长的威胁.
- 已识别的点和分子为开发安全,有效和负担得起的抗菌药物提供了基础.
- 重新审视开发策略和协调程序可以加快新一代抗生素的开发,减轻抗菌药物耐药性危机.
相关概念视频
Antibiotic Selection
59.4K
Overview
59.4K
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Gene Regulation in Microbial Communities: Quorum Sensing
524
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
524
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K


